Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of buffers

The recognition and management of acid–base disorders is a commonplace activity for intensivists. Despite the frequency with which non-bicarbonate-losing forms of metabolic acidosis such as lactic acidosis occurs in critically ill patients, treatment is controversial. This article describes the prop...

Descripción completa

Detalles Bibliográficos
Autores principales: Gehlbach, Brian K, Schmidt, Gregory A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522834/
https://www.ncbi.nlm.nih.gov/pubmed/15312208
http://dx.doi.org/10.1186/cc2865
_version_ 1782121857734934528
author Gehlbach, Brian K
Schmidt, Gregory A
author_facet Gehlbach, Brian K
Schmidt, Gregory A
author_sort Gehlbach, Brian K
collection PubMed
description The recognition and management of acid–base disorders is a commonplace activity for intensivists. Despite the frequency with which non-bicarbonate-losing forms of metabolic acidosis such as lactic acidosis occurs in critically ill patients, treatment is controversial. This article describes the properties of several buffering agents and reviews the evidence for their clinical efficacy. The evidence supporting and refuting attempts to correct arterial pH through the administration of currently available buffers is presented.
format Text
id pubmed-522834
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5228342004-10-17 Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of buffers Gehlbach, Brian K Schmidt, Gregory A Crit Care Review The recognition and management of acid–base disorders is a commonplace activity for intensivists. Despite the frequency with which non-bicarbonate-losing forms of metabolic acidosis such as lactic acidosis occurs in critically ill patients, treatment is controversial. This article describes the properties of several buffering agents and reviews the evidence for their clinical efficacy. The evidence supporting and refuting attempts to correct arterial pH through the administration of currently available buffers is presented. BioMed Central 2004 2004-05-05 /pmc/articles/PMC522834/ /pubmed/15312208 http://dx.doi.org/10.1186/cc2865 Text en Copyright © 2004 BioMed Central Ltd
spellingShingle Review
Gehlbach, Brian K
Schmidt, Gregory A
Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of buffers
title Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of buffers
title_full Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of buffers
title_fullStr Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of buffers
title_full_unstemmed Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of buffers
title_short Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of buffers
title_sort bench-to-bedside review: treating acid–base abnormalities in the intensive care unit – the role of buffers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522834/
https://www.ncbi.nlm.nih.gov/pubmed/15312208
http://dx.doi.org/10.1186/cc2865
work_keys_str_mv AT gehlbachbriank benchtobedsidereviewtreatingacidbaseabnormalitiesintheintensivecareunittheroleofbuffers
AT schmidtgregorya benchtobedsidereviewtreatingacidbaseabnormalitiesintheintensivecareunittheroleofbuffers

Ejemplares similares